Last Rebalance

RELX PLC (REL.L) · INCREASE · Net Flow -£922.26

Analysis: RELX demonstrates exceptional earnings quality by embedding proprietary generative AI models directly into its legal, scientific, and risk workflows, ensuring deep client retention and high recurring revenue.

Bull Case: Rapid commercial adoption of premium AI-driven analytical legal modules drives higher subscription growth and operating margin expansion.

Bear Case: Open-source legal LLMs could democratize information discovery, depressing long-term pricing power for premium proprietary databases.

Reason: We increase this structural winner to 28% to lean into its strong recurring revenue base and superior capability to commercialize enterprise AI.

Key Risk: Disruption of premium database pricing by advanced open-source AI legal models.

London Stock Exchange Group PLC (LSEG.L) · INCREASE · Net Flow -£554.98

Analysis: LSEG acts as a critical institutional financial data engine, leveraging its multi-year Microsoft strategic partnership to deploy advanced workspace AI tools directly to global capital markets.

Bull Case: Successful upselling of Microsoft-co-developed enterprise analytics leads to meaningful average revenue per user growth across institutional desks.

Bear Case: Integration delays or sluggish enterprise software spending across investment banking clients could slow structural data division growth.

Reason: Increasing the weight leverages LSEG's deep capital market data infrastructure which remains highly insulated from generic LLM commoditisation.

Key Risk: Slowing institutional tech budgets delaying the adoption of new workspace features.

The Sage Group plc (SGE.L) · DECREASE · Net Flow +£442.90

Analysis: Sage successfully embeds copilot capabilities into its core SME accounting software, but faces intense competition from global cloud rivals.

Bull Case: Automated accounting workflows drive high retention and encourage micro-businesses to upgrade to premium tiers.

Bear Case: Intensifying price competition from agile cloud native competitors limits margin expansion within domestic markets.

Reason: Reduced slightly to fund higher conviction positions with stronger institutional data moats and superior pricing power.

Key Risk: Price undercutting from international accounting platform competitors.

Moneysupermarket.com Group PLC (MONY.L) · DECREASE · Net Flow +£820.72

Analysis: Moneysupermarket uses algorithmic search optimization to drive consumer insurance and energy switching, benefiting from automated direct consumer matching engines.

Bull Case: Spikes in consumer insurance premiums drive elevated insurance switching volumes across their digital platform.

Bear Case: Direct generative search engines could bypass traditional aggregator sites entirely, reducing organic inbound web traffic.

Reason: Reduced to mitigate long term risk of search engine structural shifting, while maintaining a high cash generative consumer anchor.

Key Risk: Search engine landscape updates impacting consumer traffic acquisition cost.

Spire Healthcare Group plc (SPI.L) · INCREASE · Net Flow -£450.32

Analysis: Spire represents a defensive operational asset capitalizing on persistent UK healthcare capacity constraints, utilizing diagnostic automation to optimize patient flow.

Bull Case: Continued robust private medical insurance enrollment boosts structural private hospital utilization rates.

Bear Case: Severe nursing or specialist clinical staff shortages push operating costs higher, contracting margins.

Reason: Increased to 12% to enhance overall portfolio resilience and add non-correlated defensive cash flows during market volatility.

Key Risk: Escalating clinical staff costs squeezing hospital operational margins.

AstraZeneca PLC (AZN.L) · INCREASE · Net Flow -£750.47

Analysis: AstraZeneca uses deep learning computational chemistry platforms to rapidly accelerate oncology drug discovery timelines and clinical trial design.

Bull Case: Regulatory approvals for high-margin targeted oncology treatments create structural new revenue streams.

Bear Case: Late-stage pipeline asset trial failures lead to significant research and development capital write-downs.

Reason: Increased allocation to 8% to scale exposure to computational biology leaders possessing resilient global pipelines.

Key Risk: Clinical trial pipeline failures for major late-stage drug candidates.

Big Yellow Group PLC (BYG.L) · ENTER · Net Flow -£1,270.45

Analysis: Big Yellow Group offers highly resilient self-storage asset infrastructure, integrating automated dynamic pricing models to optimize rental yields.

Bull Case: Favourable domestic moving trends and space constraints sustain high core storage occupancy levels.

Bear Case: Pronounced economic downturn reduces consumer discretionary spending and storage space requirements.

Reason: Added as a defensive asset with automated yield tools to further diversify risk away from pure tech platforms.

Key Risk: Broad consumer real estate downturn reducing core storage occupancy.

Hikma Pharmaceuticals PLC (HIK.L) · ENTER · Net Flow -£1,270.45

Analysis: Hikma provides highly diversified generic and injectable medicine production, leveraging automated smart manufacturing to optimize supply chains.

Bull Case: Expansion of the high-margin injectables portfolio successfully captures market share in core global regions.

Bear Case: Intense competitive pricing pressure in generic markets erodes baseline manufacturing margins.

Reason: Added to satisfy the mandatory ADD requirement while introducing steady, tech-enabled healthcare manufacturing cash flows.

Key Risk: Pricing erosion in highly competitive global generic drug markets.

Scottish Mortgage Investment Trust PLC (SMT.L) · EXIT · Net Flow +£2,657.23

Analysis: Scottish Mortgage holds substantial exposure to unlisted private tech assets, presenting heightened valuation volatility and capital concentration risk.

Bull Case: Substantial valuation write-ups across late-stage private technology portfolio companies.

Bear Case: Prolonged high interest rates compress private equity tech valuations and widen the trust's discount to NAV.

Reason: Exited to eliminate unlisted asset valuation risk and lower the overall portfolio risk volatility profile.

Key Risk: Widening discount to net asset value and illiquidity of underlying unlisted technology firms.

Fundsmith Equity T Acc (0P0000RU7W.L) · EXIT · Net Flow +£1,298.10

Analysis: Fundsmith Equity provides exposure to global consumer and healthcare staples, but carries overlapping mega-cap concentration found elsewhere.

Bull Case: Strong global consumer brand pricing power drives superior capital compounding.

Bear Case: Underperformance of historical consumer staples relative to direct technology indexing.

Reason: Exited to eliminate redundant overlapping management fees and streamline capital into pure UK listed operators.

Key Risk: Underperformance of global consumer staples relative to targeted data platforms.